Pfizer stock: The Covid cliff is here — what to expect for 2023
Pfizer (PFE) has called for steep declines this year in its Covid vaccine and antiviral pill, but Pfizer shares reversed on Tuesday. X After hitting $100.3 billion in sales in 2022, the pharmaceutical giant expects 2023 to mark a year of decline. Pfizer has asked its Covid vaccine, Comirnaty, to generate $13.5 billion in sales … Read more